Nisa Investment Advisors
CAPR icon

Nisa Investment Advisors’s Capricor Therapeutics CAPR Stock Holding History

Nisa Investment Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7K Sell
417
-7
-2% -$187 ﹤0.01% 2156
2025
Q4 		$12.2K Sell
424
-29
-6% -$379 ﹤0.01% 2142
2025
Q3 		$3.27K Hold
453
– – ﹤0.01% 2525
2025
Q2 		$4.5K Sell
453
-761
-63% -$8.04K ﹤0.01% 2470
2025
Q1 		$11.5K Buy
1,214
+14
+1% +$194 ﹤0.01% 2064
2024
Q4 		$16.6K Buy
+1,200
New +$21K ﹤0.01% 1995

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Nisa Investment Advisors's CAPR Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Capricor Therapeutics (CAPR) stake by 1.7% in Q1 2026, selling an estimated $187 and leaving 417 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Nisa Investment Advisors first reported a position in CAPR in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.6K in Q4 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Nisa Investment Advisors held 417 shares of Capricor Therapeutics worth $12.7K as of Q1 2026.
  • Nisa Investment Advisors sold 7 Capricor Therapeutics shares in Q1 2026, an estimated $187.
  • Capricor Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2156 holding.
  • Nisa Investment Advisors first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Nisa Investment Advisors's Capricor Therapeutics position peaked at $16.6K in Q4 2024.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.